Tag Archives: USFDA

April 10, 2026

Beyond Generics: Lupin Limited’s Dapagliflozin Approval Highlights Strategic Depth in Chronic Care

February 1, 2026

USFDA Grants Final ANDA Approval to Indoco Remedies for Epilepsy Drug

December 23, 2025

USFDA Flags Compliance Issues at Sun Pharma & Aurobindo Pharma After Inspections

September 6, 2025

New Hope for Bipolar & Schizophrenia Patients : Lupin gets FDA Approval on Risperidone LAI

New Hope for Bipolar & Schizophrenia Patients : Lupin gets…

July 25, 2025

NATCO Pharma’s API Facility Cleared by U.S. FDA in Mekaguda Inspection

NATCO Pharma’s API Facility Cleared by U.S.FDA in Mekaguda Inspection…

5/5